Page last updated: 2024-10-24

chlorambucil and Angiogenesis, Pathologic

chlorambucil has been researched along with Angiogenesis, Pathologic in 2 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Molica, S1
Vacca, A1
Tucc, L1
Ribatti, D1
Kay, NE1
Shanafelt, TD1
Strege, AK1
Lee, YK1
Bone, ND1
Raza, A1

Other Studies

2 other studies available for chlorambucil and Angiogenesis, Pathologic

ArticleYear
Reversal of bone marrow angiogenesis in chronic lymphocytic leukemia following fludarabine therapy.
    Haematologica, 2005, Volume: 90, Issue:5

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Marrow; Chlorambucil; Female; Humans; Leukemia, L

2005
Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch".
    Leukemia research, 2007, Volume: 31, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Apoptosis; Biopsy, Needle; Bone M

2007